ENTRY       D02778                      Drug
NAME        Abciximab (USAN/INN);
            Abciximab (genetical recombination) (JAN);
            Reopro (TN)
FORMULA     C2109H3243N553O674S15
EXACT_MASS  47580.23
MOL_WEIGHT  47609.5914
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
             DG01811  Fibrinogen receptor antagonist
REMARK      ATC code: B01AC13
EFFICACY    Platelet aggregation inhibitor, Glycoprotein IIb/IIIa receptor antagonist
  TYPE      Monoclonal antibody
TARGET      ITGA2B/ITGB3 [HSA:3674 3690] [KO:K06476 K06493]
  PATHWAY   hsa04611(3674+3690)  Platelet activation
            hsa04640(3674+3690)  Hematopoietic cell lineage
INTERACTION  
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC13 Abciximab
                  D02778  Abciximab (USAN/INN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                D02778  Abciximab
              DG01811  Fibrinogen receptor antagonist
               D02778  Abciximab
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: other families
               Integrins
                ITGA2B/ITGB3
                 D02778  Abciximab (USAN/INN)
DBLINKS     CAS: 143653-53-6
            PubChem: 17396936
            NIKKAJI: J2.137.234J
///
